Jinxin Fertility Group Limited (abbreviated as JXR) filed its monthly return for the period ended 31 July 2026, confirming a static capital structure for the month.

Authorised Capital • Authorised share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001, representing total authorised capital of USD 50,000.

Issued Shares and Public Float • Issued share count held steady at 2.71 billion ordinary shares, with no treasury shares on the balance sheet. • The company affirmed compliance with Hong Kong’s minimum 25% public-float requirement.

Equity Incentive Schemes • No share options, warrants, convertibles or other equity instruments were exercised or issued during July. • The outstanding pool under the 2025 Share Scheme—originally covering 140.84 million shares—remained untouched during the month.

Share Repurchase Status • JXR repurchased a cumulative 88.46 million shares between 27 March 2026 and 3 July 2026. These shares are slated for cancellation but were still outstanding as of 31 July 2026, leaving the month-end issued share total unchanged.

Governance Confirmation The filing was signed by Chief Executive Officer, Acting Chief Financial Officer and Executive Director Dong Yang, who confirmed full compliance with Hong Kong listing rules and all applicable regulatory requirements.